Get the app!
Back to Trades

Wildman Daniel George

DirectorCIK 0001952679

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Wildman Daniel George, Director, accounts for 3 disclosed filings worth $544.9K, all concentrated in UroGen Pharma Ltd. (URGN), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Jun 24URGN
UroGen Pharma Ltd.
Wildman Daniel GeorgeDirectorAward$349.9K
Dec 1URGN
UroGen Pharma Ltd.
Wildman Daniel GeorgeDirectorExercise$0
Aug 27URGN
UroGen Pharma Ltd.
Wildman Daniel GeorgeDirectorAward$195.0K

3 filings